226 related articles for article (PubMed ID: 24507043)
21. Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment.
Hong JH; Choi YK; Min BK; Park KS; Seong K; Lee IK; Kim JG
Diabetes Res Clin Pract; 2015 Jul; 109(1):64-70. PubMed ID: 25998917
[TBL] [Abstract][Full Text] [Related]
22. Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates.
Troutt JS; Butterfield AM; Konrad RJ
J Clin Lab Anal; 2013 Nov; 27(6):504-10. PubMed ID: 24218134
[TBL] [Abstract][Full Text] [Related]
23. Correlation of hepcidin level with insulin resistance and endocrine glands function in major thalassemia.
Al-Hakeim HK; Al-Khakani MM; Al-Kindi MA
Adv Clin Exp Med; 2015; 24(1):69-78. PubMed ID: 25923089
[TBL] [Abstract][Full Text] [Related]
24. Correlation between hepcidin level and renal anemia.
Yang LN; Zhang P; Tang F; Wang G; Li FE
Genet Mol Res; 2014 Sep; 13(3):7407-10. PubMed ID: 25222239
[TBL] [Abstract][Full Text] [Related]
25. Increased serum iron in preeclamptic women is likely due to low hepcidin levels.
Brunacci F; Rocha VS; De Carli E; Espósito BP; Ruano R; Colli C
Nutr Res; 2018 May; 53():32-39. PubMed ID: 29685625
[TBL] [Abstract][Full Text] [Related]
26. Hepcidin levels in children with chronic liver disease.
Cakir M; Erduran E; Turkmen ES; Aliyazicioglu Y; Reis GP; Cobanoglu U; Demir S
Saudi J Gastroenterol; 2015; 21(5):300-5. PubMed ID: 26458857
[TBL] [Abstract][Full Text] [Related]
27. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
[TBL] [Abstract][Full Text] [Related]
28. Association between hepcidin, haemoglobin level and iron status in stage 4 chronic kidney disease patients with anaemia.
Mogadam RA; Nemati A; Amani F; Ghorbanihaghjo A; Argani H; Bashardoust B
J Pak Med Assoc; 2015 Apr; 65(4):354-7. PubMed ID: 25976565
[TBL] [Abstract][Full Text] [Related]
29. Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients.
Ford BA; Eby CS; Scott MG; Coyne DW
Kidney Int; 2010 Oct; 78(8):769-73. PubMed ID: 20668427
[TBL] [Abstract][Full Text] [Related]
30. Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate.
Peters HP; Laarakkers CM; Swinkels DW; Wetzels JF
Nephrol Dial Transplant; 2010 Mar; 25(3):848-53. PubMed ID: 19854845
[TBL] [Abstract][Full Text] [Related]
31. Association of hepcidin-25 with survival after kidney transplantation.
Eisenga MF; Dullaart RP; Berger SP; Sloan JH; de Vries AP; Bakker SJ; Gaillard CA
Eur J Clin Invest; 2016 Dec; 46(12):994-1001. PubMed ID: 27696386
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of serum NGAL and hepcidin levels in chronic kidney disease patients.
Avci Çiçek E; Rota S; Dursun B; Kavalci E
Ren Fail; 2016; 38(1):35-9. PubMed ID: 26627016
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of serum hepcidin and iron levels in patients with PCOS: a case-control study.
Hossein Rashidi B; Shams S; Shariat M; Kazemi Jaliseh H; Mohebi M; Haghollahi F
J Endocrinol Invest; 2017 Jul; 40(7):779-784. PubMed ID: 28276006
[TBL] [Abstract][Full Text] [Related]
34. Hepcidin as a Biomarker of Impaired Renal Function in Rat Models for Chronic Allograft Nephropathy.
Xue D; Zhou C; Shi Y; Lu H; He X
Med Sci Monit; 2016 Feb; 22():608-16. PubMed ID: 26907911
[TBL] [Abstract][Full Text] [Related]
35. GDF15 is related to anemia and hepcidin in kidney allograft recipients.
Malyszko J; Koc-Zorawska E; Malyszko JS; Glowinska I; Mysliwiec M; Macdougall IC
Nephron Clin Pract; 2013; 123(1-2):112-7. PubMed ID: 23797049
[TBL] [Abstract][Full Text] [Related]
36. The role of hepcidin-25 in kidney transplantation.
Chan W; G Ward D; McClean A; A Bosch J; Jones D; Kaur O; Drayson M; Whitelegg A; Iqbal T; McTernan PG; Tselepis C; Borrows R
Transplantation; 2013 Jun; 95(11):1390-5. PubMed ID: 23552742
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory Markers and Hepcidin are Elevated but Serum Iron is Lower in Obese Women of Reproductive Age.
Aguree S; Reddy MB
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33466578
[TBL] [Abstract][Full Text] [Related]
38. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.
Zaritsky J; Young B; Wang HJ; Westerman M; Olbina G; Nemeth E; Ganz T; Rivera S; Nissenson AR; Salusky IB
Clin J Am Soc Nephrol; 2009 Jun; 4(6):1051-6. PubMed ID: 19406957
[TBL] [Abstract][Full Text] [Related]
39. Hepcidin is linked to hypoferremia in patients with rheumatic valve disease.
Akçay M; Yeter E; Ayhan H; Durmaz T; Keleş T; Kasapkara HA; Bilen E; Bozkurt E
Clin Appl Thromb Hemost; 2015 Nov; 21(8):745-9. PubMed ID: 24569625
[TBL] [Abstract][Full Text] [Related]
40. Iron metabolism, hepcidin, and anemia in orthotopic heart transplantation recipients treated with mammalian target of rapamycin.
Przybylowski P; Malyszko JS; Macdougall IC; Malyszko J
Transplant Proc; 2013; 45(1):387-90. PubMed ID: 23375326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
